26 June 2019 - Use of real-world evidence is becoming increasingly common to aid the clinical development process and provide important data for pricing discussions once medicines have been approved.

Real-world evidence has long been seen as a transformative tool for pharma, and in fact has already disrupted several pharma functions.

“Healthcare today is facing enormous challenges around figuring out how to choose the best treatments. What treatments work best, for whom and under what circumstances?

“Real-world data gives us the opportunity to bring the safest, most effective treatments to market and to ensure that the patients who can benefit the most have access to and are receiving those treatments.”

Read Pharmaphorum article